[go: up one dir, main page]

WO2014044869A3 - Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin - Google Patents

Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin Download PDF

Info

Publication number
WO2014044869A3
WO2014044869A3 PCT/EP2013/069825 EP2013069825W WO2014044869A3 WO 2014044869 A3 WO2014044869 A3 WO 2014044869A3 EP 2013069825 W EP2013069825 W EP 2013069825W WO 2014044869 A3 WO2014044869 A3 WO 2014044869A3
Authority
WO
WIPO (PCT)
Prior art keywords
polyhexanide
octenidine
carrier
medical preparation
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2013/069825
Other languages
English (en)
French (fr)
Other versions
WO2014044869A2 (de
Inventor
Wolfgang Winkelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP13770871.5A priority Critical patent/EP2897617A2/de
Publication of WO2014044869A2 publication Critical patent/WO2014044869A2/de
Publication of WO2014044869A3 publication Critical patent/WO2014044869A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Die vorliegende Erfindung betrifft pharmazeutische Zusammensetzungen und insbesondere medizinische Präparate, die einen Träger und ein Antiseptikum enthalten, wobei das Antiseptikum ausgewählt ist aus der Gruppe bestehend aus Polyhexanid, Octenidin und Mischungen davon. Die Erfindung betrifft auch verschiedene Produkte, die ein erfindungsgemäßes medizinisches Präparat aufweisen, sowie spezifische Verwendungen des medizinischen Präparats.
PCT/EP2013/069825 2012-09-24 2013-09-24 Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin Ceased WO2014044869A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13770871.5A EP2897617A2 (de) 2012-09-24 2013-09-24 Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012019194.4 2012-09-24
DE102012019194.4A DE102012019194B4 (de) 2012-09-24 2012-09-24 Medizinisches Präparat umfassend einen Träger mit Polyhexanid oder Octenidin

Publications (2)

Publication Number Publication Date
WO2014044869A2 WO2014044869A2 (de) 2014-03-27
WO2014044869A3 true WO2014044869A3 (de) 2014-06-12

Family

ID=49274617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/069825 Ceased WO2014044869A2 (de) 2012-09-24 2013-09-24 Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin

Country Status (3)

Country Link
EP (1) EP2897617A2 (de)
DE (1) DE102012019194B4 (de)
WO (1) WO2014044869A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441513B2 (en) 2014-04-22 2019-10-15 Christian Arnold Oral delivery system
US10786448B2 (en) 2018-01-18 2020-09-29 Christian Arnold Chewing gum composition comprising polyhexanide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220227997A1 (en) 2019-05-14 2022-07-21 Coloplast A/S Elastomeric silicone compositions comprising glycerol, cyclodextrin and octenidine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10162058A1 (de) * 2001-12-17 2003-07-24 Cospharcon Gmbh Gefäßaktive, juckreiz- und entzündungslindernde Zubereitung zur Minimierung der unangenehmen Begleiterscheinungen hämorrhoidaler Affekte und Ekzeme im Analbereich sowie als unterstützende Maßnahme zur Intertrigo- und Dekubitus-Prophylaxe bei entsprechend disponierten Personen.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644060B1 (fr) 1989-03-10 1993-10-29 Anben Ste Civile Medicament, notamment pour le traitement de maladies a virus du type herpes cutane, oculaire et genital
US5665333A (en) 1995-01-17 1997-09-09 Homola; Andrew M. Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
US5786282A (en) 1997-02-25 1998-07-28 Barnhardt Manufacturing Company Opened wet processed intermediate natural fiber product suitable for formation into end use fiber products with long-lasting antimicrobial properties and method
DE202006016821U1 (de) 2005-11-02 2007-03-29 Riesinger, Birgit Absorbierender Körper zur Anbringung an menschliche oder tierische Körperoberflächen
DE102006015271A1 (de) 2006-04-01 2007-10-11 Lohmann & Rauscher Gmbh & Co. Kg Biguanidhaltige Liposomen
ATE464916T1 (de) 2006-11-06 2010-05-15 Lohmann & Rauscher Gmbh & Co Kg Produkt zur versorgung von entzündungen, druckstellen und/oder aphten im oralbereich sowie verwendung eines solchen produkts
WO2010031096A1 (de) 2008-09-18 2010-03-25 Croma-Pharma Gesellschaft M.B.H. Antimikrobiell und antiviral wirkende zusammensetzunq
DE102009035970A1 (de) 2009-08-04 2011-02-17 Heraeus Kulzer Gmbh Antimikrobiell ausgestattete Dentalmaterialien, insbesondere zur Verhinderung von Plaqueanlagerungen
DE102009049506A1 (de) 2009-10-15 2011-04-21 Schülke & Mayr GmbH Octenidindihydrochlorid enthaltende Wundauflage zur Anwendung bei der Antiseptik von Kathetereintrittsstellen
US9044524B2 (en) 2009-10-30 2015-06-02 Ethicon, Inc. Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
DE102010013075A1 (de) 2010-03-26 2011-09-29 B. Braun Melsungen Ag Antimikrobielle Wundauflage
DE202010007433U1 (de) 2010-04-20 2011-06-01 Klosterfrau Berlin GmbH, 12277 Gel, insbesondere Gleitgel
US20120070480A1 (en) 2010-09-17 2012-03-22 3M Innovative Properties Company Antimicrobial disposable absorbent articles
DE202011108805U1 (de) 2011-09-02 2012-09-03 BLüCHER GMBH Wundauflage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10162058A1 (de) * 2001-12-17 2003-07-24 Cospharcon Gmbh Gefäßaktive, juckreiz- und entzündungslindernde Zubereitung zur Minimierung der unangenehmen Begleiterscheinungen hämorrhoidaler Affekte und Ekzeme im Analbereich sowie als unterstützende Maßnahme zur Intertrigo- und Dekubitus-Prophylaxe bei entsprechend disponierten Personen.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J DISSEMOND ET AL: "Praxisorientierte Expertenempfehlung zur Behandlung kritisch kolonisierter und lokal infizierter Wunden mit Polihexanid", WUNDMANAGEMENT, 1 March 2009 (2009-03-01), pages 61 - 68, XP055092187 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441513B2 (en) 2014-04-22 2019-10-15 Christian Arnold Oral delivery system
US10786448B2 (en) 2018-01-18 2020-09-29 Christian Arnold Chewing gum composition comprising polyhexanide

Also Published As

Publication number Publication date
DE102012019194A1 (de) 2014-04-17
EP2897617A2 (de) 2015-07-29
DE102012019194B4 (de) 2024-08-01
WO2014044869A2 (de) 2014-03-27

Similar Documents

Publication Publication Date Title
WO2014097151A3 (en) Autotaxin inhibitors
EP4414376A3 (de) Neues depsipeptid und verwendungen davon
WO2012104275A3 (en) Nanoparticles delivery systems, preparation and uses thereof
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
EP3093023A4 (de) Pharmazeutische zusammensetzung zur krebsbehandlung und pharmazeutische zubereitung zur krebsbehandlung mit dieser zusammensetzung als wirkstoff
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
EP3279210A4 (de) Peptid mit antikrebswirkung und pharmazeutische zusammensetzung sowie nahrungsergänzungszusammensetzung zur vorbeugung und behandlung von krebs jeweils damit als wirkstoff
MX363699B (es) Producto de comicronizacion que comprende acetato de ulipristal.
IN2014DN10449A (de)
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
EP3068436A4 (de) Topische pharmazeutische, kosmetische und desinfektionsmittel mit phosphatidylcholin
WO2014044869A3 (de) Medizinisches präparat umfassend einen träger mit polyhexanid oder octenidin
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
EP2476420B8 (de) Pharmazeutische zusammensetzung mit antimikrobieller und schnell heilender wirkung zur externen verabreichung sowie herstellungsverfahren dafür
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
EP2870964A4 (de) Zusammensetzung zur prävention oder behandlung von colitis mit s-allyl-l-cystein als wirkstoff und medizinische zubereitung damit
EP3323411A4 (de) Zusammensetzung zur hemmung der angiogenese mit nanopartikel-glaskörper-basiertem proteinkomplex als wirkstoff sowie verwendung davon
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
HK1223852A1 (zh) 睪丸酮凝膠組合物及相關方法
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2012079872A3 (de) Haarbehandlungsmittel enthaltend dicocoyl pentaerythrityl distearyl citrate
WO2012167903A3 (de) Kosmetische oder dermatologische peelingzubereitung

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13770871

Country of ref document: EP

Kind code of ref document: A2